Ansm - activities

Covid: the French Medicines Agency releases latest data about vaccine side effects

As the vaccination campaign is expected to increase even more in France over the coming weeks, the ANSM – the National Medicines Agency – has unveiled the conclusions of their latest investigation on side effects noticed following Covid-19 vaccination. Keep reading to find out more.

AstraZeneca vaccine: three new cases of thrombosis, and two deaths reported in France

According to the Agence du Médicament – Medicines Agency (ANSM) – three new cases of thrombosis related to AstraZeneca vaccine, including two more deaths, have been reported between March 19 and 25 in France.

Covid: France has approved two monoclonal antibody therapies

This Monday March 15, the Agence du Médicament (French Medicines Agency) announced that two monoclonal antibody therapies, namely REGN-COV2 and Eli Lilly laboratory's therapy based on bamlanivimab and etesevimab were now approved in France.

AstraZeneca vaccine: enhanced vigilance after adverse effects reported in 149 health workers

AstraZeneca vaccine subject to worries… This Thursday February 11, the ANSM said that in 10,000 health workers vaccinated, 149 of them developed mild but harsh side effects such as fever, headache and flu-like condition. Adverse effects required for some to call in sick.

Coronavirus: France bans hydroxychloroquine

According to a decree published this May 27th in the Journal Officiel, the French government has decided to ban the use of hydroxychloroquine to treat Covid-19.

Coronavirus: towards medicines shortage in France?

Should France get ready to face medicines shortage? In an interview with Le Figaro, published on April 7, the Agence Nationale de Sécurité du Médicament or French Agency for the Safety of Medicine has said they only have a “fifteen-day” window of visibility for some products. Let’s have a look on the situation.